Advertisement

Topics

Roche And Spark Therapeutics Agree To Extend Merger Deadline

22:22 EDT 8 Jul 2019 | FinanzNachrichten

SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG (RHHBY) and Spark Therapeutics (ONCE) agreed to extend the deadline for the Swiss drugmaker's $4.3 billion acquisition of the U.S. biotechnology co...

Original Article: Roche And Spark Therapeutics Agree To Extend Merger Deadline

NEXT ARTICLE

More From BioPortfolio on "Roche And Spark Therapeutics Agree To Extend Merger Deadline"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...